InnAccel Technologies
Frugal medical devices for the next billion patients.

Overview
Why MJV invested
Frugal medtech is a decade-long game, and the InnAccel founders have the exact temperament for it — Stanford Biodesign training, deep clinical fieldwork, and a patents-first discipline. Their willingness to build slowly and correctly for the next billion patients is why we backed them. Very few Indian teams have shown they can carry a medical device from clinical insight through regulatory approvals to manufacturing at cost points that district hospitals can actually afford — InnAccel has done it repeatedly. That platform of engineering, clinical, and regulatory muscle is the compounding asset we're investing behind.
- 01
Portfolio of CE-marked and USFDA-cleared devices in obstetrics and critical care
- 02
In-house R&D lab producing multiple novel devices per year
- 03
Founder-led team with Stanford Biodesign lineage and 100+ patents
Press & Media
Building in the same category?
Pitch us →